Kadans Science Partner will add Windrush Innovation Centre in Oxford, UK to its Pan-European portfolio. The asset will be freehold acquired from Tozi Limited. Kadans intends to demolish the existing building and create over 60,000 sq ft of new high specification laboratory and office space in partnership with the tenant, Oxford Biomedica.
Oxford is a global centre of excellence in life science innovation. The cluster is anchored by the University of Oxford which was recently named the number 1 university in the world (Times World University Ranking 2022). The Oxford cluster spans a whole range of life sciences enterprise including drug discovery, diagnostics, medical devices, regenerative medicine and genomics. With world leading academics, researchers and clinicians Oxford continues to be at the forefront of scientific innovation.
James Sheppard, Managing Director (UK & Ireland) said: ‘We are delighted to continue to be building our portfolio in Oxford. The development at Windrush Innovation Centre will provide much needed, high specification, laboratory space in the Oxford market. We look forward to a continued productive relationship with the tenant, Oxford Biomedica, as they build their position as a quality and innovation-led viral vector CDMO.’
Freddie Owen, Partner at Knight Frank commented: ‘Knight Frank are delighted to advise Kadans on another exciting acquisition in Oxford. After successfully acquiring Oxford Biomedica’s HQ facility in 2022, this new development located next door will be a great addition to the South Oxford Life Science cluster’.
Tozi Limited commented ‘In keeping with our approach across our entire portfolio, we have always maintained a productive and open relationship with the tenant Oxford Biomedica, helping to facilitate planning permission for the brand new state of the art R&D campus.’
Oliver Spero of Cyril Leonard ‘on behalf of our clients, we have secured long indexed linked assets which have delivered returns commensurate with their requirements and in this case significant capital growth. Cyril Leonard provided a full service for the clients and will start the process again by seeking to reinvest the proceeds into good quality logistics and build up the portfolio further.’
With the acquisition of Windrush Innovation Centre the Kadans portfolio now comprises of over 50 buildings and numerous projects under development in the Netherlands, United Kingdom, Germany, Belgium, France and Spain. Kadans aspires to partner with universities, venture capital firms and innovative organisations to create one strong knowledge-sharing ecosystem of scientific enterprise across Europe.
Kadans was supported in this transaction by Knight Frank and Mills & Reeve acted as legal advisors for Kadans. Cyril Leonard advised the vendor and Cripps acted as legal advisors.
About Kadans Science Partner
Kadans Science Partner is the European leader investing in the development of ecosystems and real estate with a dedicated focus on the knowledge intensive sector. Kadans has invested across various specific areas, like agri-tech in Wageningen, life sciences in Leiden, and cell & gene therapy in Stevenage, UK. Kadans provides its tenants with an array of additional services tailored to their specific needs. In December 2020, Kadans was acquired by AXA IM Alts, which, as a long- term capital partner, has allowed us to significantly accelerate our growth.
Kadans is currently present on 26 campuses, in 7 countries, where it operates over 8 million sq ft of space for over 450 tenants, including start-ups, scale-ups, corporates, government bodies and educational institutes. Kadans has a solid view of the developments our tenants and partners are currently working on and which parties in our network could benefit from connecting.
+44 20 7802 2602